FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...